By Sabela Ojea

 

Thermo Fisher Scientific lowered its guidance for the year after reporting a drop in profit and revenue in the second quarter.

The Waltham, Mass., life-sciences and laboratory equipment company on Tuesday guided for full-year revenue of $43.4 billion to $44.0 billion, down from a prior forecast of $45.3 billion.

The company also expects adjusted earnings per share -- which strips out one-time items -- of $22.28 to $22.72, down from $23.70 previously.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

July 26, 2023 06:38 ET (10:38 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Thermo Fisher Scientific.
Thermo Fisher Scientific (NYSE:TMO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Thermo Fisher Scientific.